Table 2

Table showing clinical characteristics across groups defined by UCPCR result

UCPCR groupP value*
<0.001 nmol/mmol (n = 184)≥0.001 to <0.03 nmol/mmol (n = 483)≥0.03 to <0.2 nmol/mmol (n = 187)≥0.2 nmol/mmol (n = 70)
Age at diagnosis (years)10 (6–16)11 (6–16)12 (8–21)16 (13–21)0.0001
Diabetes duration (years)20.9 (14.9–26.9)19.1 (11.5–27.7)15.0 (8.2–23.4)13.9 (7.9–21.6)0.0001
Insulin dose (units/kg/24 h)0.77 (0.61–0.93)0.78 (0.60–0.97)0.77 (0.60–1.00)0.74 (0.55–1.01)0.9
CSII use (%)16159100.2
HbA1c level
 %8.9 (7.8–10.2)8.6 (7.9–9.7)8.7 (7.9–9.8)9.1 (7.6–10.3)0.3
 mmol/mol74707276
BMI (kg/m2)24.0 (22.6–26.5)24.8 (23.2–27.7)25.3 (23.2–27.8)24.8 (23.0–26.6)0.7
  • Data are the median (IQR).

  • * Kruskal-Wallis test.

  • BMI results for pediatric patients adjusted to equivalent BMI for age 22 years.